Brown Advisory’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$374K Buy
1,667
+73
+5% +$18.2K ﹤0.01% 1148
2025
Q4
$384K Sell
1,594
-87
-5% -$22.2K ﹤0.01% 1139
2025
Q3
$460K Buy
1,681
+95
+6% +$25.9K ﹤0.01% 1080
2025
Q2
$409K Buy
1,586
+240
+18% +$57.3K ﹤0.01% 1069
2025
Q1
$301K Sell
1,346
-216
-14% -$50.4K ﹤0.01% 1132
2024
Q4
$357K Buy
1,562
+321
+26% +$77.3K ﹤0.01% 1107
2024
Q3
$303K Sell
1,241
-15
-1% -$3.35K ﹤0.01% 1108
2024
Q2
$240K Sell
1,256
-67
-5% -$13.6K ﹤0.01% 1125
2024
Q1
$262K Buy
1,323
+160
+14% +$29.3K ﹤0.01% 1108
2023
Q4
$200K Buy
+1,163
New +$179K ﹤0.01% 1163
2023
Q3
Sell
-1,166
Closed -$255K 1222
2023
Q2
$255K Sell
1,166
-12
-1% -$2.67K ﹤0.01% 1053
2023
Q1
$258K Buy
1,178
+67
+6% +$14.5K ﹤0.01% 1070
2022
Q4
$231K Buy
1,111
+2
+0.2% +$439 ﹤0.01% 1089
2022
Q3
$242K Buy
+1,109
New +$252K ﹤0.01% 1019
2022
Q2
Sell
-1,040
Closed -$252K 1139
2022
Q1
$252K Buy
1,040
+116
+13% +$28.1K ﹤0.01% 1007
2021
Q4
$241K Hold
924
﹤0.01% 1117
2021
Q3
$244K Buy
924
+75
+9% +$20.5K ﹤0.01% 1000
2021
Q2
$210K Sell
849
-569
-40% -$120K ﹤0.01% 1017
2021
Q1
$275K Buy
1,418
+90
+7% +$18K ﹤0.01% 966
2020
Q4
$283K Buy
+1,328
New +$265K ﹤0.01% 887
2013
Q3
Sell
-14,547
Closed -$657K 912
2013
Q2
$657K Buy
+14,547
New +$690K ﹤0.01% 541

Other funds holding RMD

Brown Advisory's RMD Position: Q1 2026 in Review

Brown Advisory increased its ResMed (RMD) stake by 4.6% in Q1 2026, buying an estimated $18.2K and bringing the position to 1,667 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.

Brown Advisory first reported a position in RMD in Q2 2013 and has held it in 21 quarters since. The position peaked at $657K in Q2 2013. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Brown Advisory held 1,667 shares of ResMed worth $374K as of Q1 2026.
  • Brown Advisory bought 73 ResMed shares in Q1 2026, an estimated $18.2K.
  • ResMed made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #1148 holding.
  • Brown Advisory first reported a position in ResMed in Q2 2013 and has held it in 21 quarters since.
  • Brown Advisory's ResMed position peaked at $657K in Q2 2013.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.